Nicobrevin for smoking cessation

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 12, 2006, Pages

  Stead, Lindsay F ^a   Lancaster, Tim ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOBREVIN; NICOTINE; PLACEBO; QUININE; TERPENE; VALERIC ACID DERIVATIVE;

CONTROLLED STUDY; DRUG EFFICACY; HUMAN; LONG TERM CARE; MANTEL HAENSZEL TEST; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SMOKING CESSATION; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; TREATMENT OUTCOME; SMOKING;

PENTANOIC ACIDS; QUININE; SMOKING; SMOKING CESSATION; TERPENES;

EID: 33745029533     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005990     Document Type: Review

References (5)

1. Dankwa E, Perry L, Perkins A. A double-blind, placebo-controlled study to determine the efficacy of Nicobrevin anti-smoking capsules. Britiah Journal of Clinical Practice 1988;42(9):359-63.
2. Schmidt F. Medical support of nicotine withdrawal. report on a double blind trial in over 5000 smokers [Medikamentose unterstutzung der raucherentwohnung: bericht uber versuche an uber 5000 rauchern im doppelblindversuch]. Munchen Med Wochenschr 1974;116(11):557-64.
3. Nicobrevin/home page. http://www.nicobrevin.com (accessed 2/2/2006) 2006.
4. Campaign for Tobacco-Free Kids. QuiTIP - Other Cessation products. https://secure.tobaccofreekids.org/Cessation/ListOther.asp (accessed 7/2/2006) 2005.
5. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100:299-303.